Item 1. Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares, which are reflected in thousands, and per-share amounts)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Net sales: | | | | | | | |
Products | $ | 66,886 | | | $ | 73,929 | | | $ | 163,344 | | | $ | 170,317 | |
Services | 23,867 | | | 20,907 | | | 46,984 | | | 41,673 | |
Total net sales | 90,753 | | | 94,836 | | | 210,328 | | | 211,990 | |
| | | | | | | |
Cost of sales: | | | | | | | |
Products | 42,424 | | | 46,795 | | | 100,864 | | | 107,560 | |
Services | 6,058 | | | 6,065 | | | 12,338 | | | 12,122 | |
Total cost of sales | 48,482 | | | 52,860 | | | 113,202 | | | 119,682 | |
Gross margin | 42,271 | | | 41,976 | | | 97,126 | | | 92,308 | |
| | | | | | | |
Operating expenses: | | | | | | | |
Research and development | 7,903 | | | 7,457 | | | 15,599 | | | 15,166 | |
Selling, general and administrative | 6,468 | | | 6,201 | | | 13,254 | | | 12,808 | |
Total operating expenses | 14,371 | | | 13,658 | | | 28,853 | | | 27,974 | |
| | | | | | | |
Operating income | 27,900 | | | 28,318 | | | 68,273 | | | 64,334 | |
Other income/(expense), net | 158 | | | 64 | | | 108 | | | (329) | |
Income before provision for income taxes | 28,058 | | | 28,382 | | | 68,381 | | | 64,005 | |
Provision for income taxes | 4,422 | | | 4,222 | | | 10,829 | | | 9,847 | |
Net income | $ | 23,636 | | | $ | 24,160 | | | $ | 57,552 | | | $ | 54,158 | |
| | | | | | | |
Earnings per share: | | | | | | | |
Basic | $ | 1.53 | | | $ | 1.53 | | | $ | 3.72 | | | $ | 3.42 | |
Diluted | $ | 1.53 | | | $ | 1.52 | | | $ | 3.71 | | | $ | 3.41 | |
| | | | | | | |
Shares used in computing earnings per share: | | | | | | | |
Basic | 15,405,856 | | | 15,787,154 | | | 15,457,810 | | | 15,839,939 | |
Diluted | 15,464,709 | | | 15,847,050 | | | 15,520,675 | | | 15,901,384 | |
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc. | Q2 2024 Form 10-Q | 1
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Net income | $ | 23,636 | | | $ | 24,160 | | | $ | 57,552 | | | $ | 54,158 | |
Other comprehensive income/(loss): | | | | | | | |
Change in foreign currency translation, net of tax | (322) | | | (95) | | | (14) | | | (109) | |
| | | | | | | |
Change in unrealized gains/losses on derivative instruments, net of tax: | | | | | | | |
Change in fair value of derivative instruments | 456 | | | (13) | | | (75) | | | (1,001) | |
Adjustment for net (gains)/losses realized and included in net income | 232 | | | (191) | | | (591) | | | (1,957) | |
Total change in unrealized gains/losses on derivative instruments | 688 | | | (204) | | | (666) | | | (2,958) | |
| | | | | | | |
Change in unrealized gains/losses on marketable debt securities, net of tax: | | | | | | | |
Change in fair value of marketable debt securities | (7) | | | 1,403 | | | 3,038 | | | 2,303 | |
Adjustment for net (gains)/losses realized and included in net income | 59 | | | 62 | | | 134 | | | 127 | |
Total change in unrealized gains/losses on marketable debt securities | 52 | | | 1,465 | | | 3,172 | | | 2,430 | |
| | | | | | | |
Total other comprehensive income/(loss) | 418 | | | 1,166 | | | 2,492 | | | (637) | |
Total comprehensive income | $ | 24,054 | | | $ | 25,326 | | | $ | 60,044 | | | $ | 53,521 | |
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc. | Q2 2024 Form 10-Q | 2
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares, which are reflected in thousands, and par value)
| | | | | | | | | | | |
| March 30, 2024 | | September 30, 2023 |
ASSETS: |
Current assets: | | | |
Cash and cash equivalents | $ | 32,695 | | | $ | 29,965 | |
Marketable securities | 34,455 | | | 31,590 | |
Accounts receivable, net | 21,837 | | | 29,508 | |
Vendor non-trade receivables | 19,313 | | | 31,477 | |
Inventories | 6,232 | | | 6,331 | |
Other current assets | 13,884 | | | 14,695 | |
Total current assets | 128,416 | | | 143,566 | |
| | | |
Non-current assets: | | | |
Marketable securities | 95,187 | | | 100,544 | |
Property, plant and equipment, net | 43,546 | | | 43,715 | |
Other non-current assets | 70,262 | | | 64,758 | |
Total non-current assets | 208,995 | | | 209,017 | |
Total assets | $ | 337,411 | | | $ | 352,583 | |
| | | |
LIABILITIES AND SHAREHOLDERS’ EQUITY: |
Current liabilities: | | | |
Accounts payable | $ | 45,753 | | | $ | 62,611 | |
Other current liabilities | 57,298 | | | 58,829 | |
Deferred revenue | 8,012 | | | 8,061 | |
Commercial paper | 1,997 | | | 5,985 | |
Term debt | 10,762 | | | 9,822 | |
Total current liabilities | 123,822 | | | 145,308 | |
| | | |
Non-current liabilities: | | | |
Term debt | 91,831 | | | 95,281 | |
Other non-current liabilities | 47,564 | | | 49,848 | |
Total non-current liabilities | 139,395 | | | 145,129 | |
Total liabilities | 263,217 | | | 290,437 | |
| | | |
Commitments and contingencies | | | |
| | | |
Shareholders’ equity: | | | |
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,337,686 and 15,550,061 shares issued and outstanding, respectively | 78,815 | | | 73,812 | |
Retained earnings/(Accumulated deficit) | 4,339 | | | (214) | |
Accumulated other comprehensive loss | (8,960) | | | (11,452) | |
Total shareholders’ equity | 74,194 | | | 62,146 | |
Total liabilities and shareholders’ equity | $ | 337,411 | | | $ | 352,583 | |
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc. | Q2 2024 Form 10-Q | 3
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)
(In millions, except per-share amounts)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Total shareholders’ equity, beginning balances | $ | 74,100 | | | $ | 56,727 | | | $ | 62,146 | | | $ | 50,672 | |
| | | | | | | |
Common stock and additional paid-in capital: | | | | | | | |
Beginning balances | 75,236 | | | 66,399 | | | 73,812 | | | 64,849 | |
Common stock issued | 752 | | | 690 | | | 752 | | | 690 | |
Common stock withheld related to net share settlement of equity awards | (222) | | | (281) | | | (1,882) | | | (1,715) | |
Share-based compensation | 3,049 | | | 2,760 | | | 6,133 | | | 5,744 | |
Ending balances | 78,815 | | | 69,568 | | | 78,815 | | | 69,568 | |
| | | | | | | |
Retained earnings/(Accumulated deficit): | | | | | | | |
Beginning balances | 8,242 | | | 3,240 | | | (214) | | | (3,068) | |
Net income | 23,636 | | | 24,160 | | | 57,552 | | | 54,158 | |
Dividends and dividend equivalents declared | (3,746) | | | (3,684) | | | (7,520) | | | (7,396) | |
Common stock withheld related to net share settlement of equity awards | (71) | | | (152) | | | (1,089) | | | (1,130) | |
Common stock repurchased | (23,722) | | | (19,228) | | | (44,390) | | | (38,228) | |
Ending balances | 4,339 | | | 4,336 | | | 4,339 | | | 4,336 | |
| | | | | | | |
Accumulated other comprehensive income/(loss): | | | | | | | |
Beginning balances | (9,378) | | | (12,912) | | | (11,452) | | | (11,109) | |
Other comprehensive income/(loss) | 418 | | | 1,166 | | | 2,492 | | | (637) | |
Ending balances | (8,960) | | | (11,746) | | | (8,960) | | | (11,746) | |
| | | | | | | |
Total shareholders’ equity, ending balances | $ | 74,194 | | | $ | 62,158 | | | $ | 74,194 | | | $ | 62,158 | |
| | | | | | | |
Dividends and dividend equivalents declared per share or RSU | $ | 0.24 | | | $ | 0.23 | | | $ | 0.48 | | | $ | 0.46 | |
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc. | Q2 2024 Form 10-Q | 4
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
| | | | | | | | | | | |
| Six Months Ended |
| March 30, 2024 | | April 1, 2023 |
Cash, cash equivalents and restricted cash, beginning balances | $ | 30,737 | | | $ | 24,977 | |
| | | |
Operating activities: | | | |
Net income | 57,552 | | | 54,158 | |
Adjustments to reconcile net income to cash generated by operating activities: | | | |
Depreciation and amortization | 5,684 | | | 5,814 | |
Share-based compensation expense | 5,961 | | | 5,591 | |
| | | |
Other | (1,971) | | | (1,732) | |
Changes in operating assets and liabilities: | | | |
Accounts receivable, net | 7,727 | | | 9,596 | |
Vendor non-trade receivables | 12,164 | | | 14,785 | |
Inventories | 53 | | | (2,548) | |
Other current and non-current assets | (4,438) | | | (4,092) | |
Accounts payable | (16,710) | | | (20,764) | |
Other current and non-current liabilities | (3,437) | | | 1,757 | |
Cash generated by operating activities | 62,585 | | | 62,565 | |
| | | |
Investing activities: | | | |
Purchases of marketable securities | (25,042) | | | (11,197) | |
Proceeds from maturities of marketable securities | 27,462 | | | 17,124 | |
Proceeds from sales of marketable securities | 4,314 | | | 1,897 | |
Payments for acquisition of property, plant and equipment | (4,388) | | | (6,703) | |
| | | |
Other | (729) | | | (247) | |
Cash generated by investing activities | 1,617 | | | 874 | |
| | | |
Financing activities: | | | |
Payments for taxes related to net share settlement of equity awards | (2,875) | | | (2,734) | |
Payments for dividends and dividend equivalents | (7,535) | | | (7,418) | |
Repurchases of common stock | (43,344) | | | (39,069) | |
| | | |
Repayments of term debt | (3,150) | | | (3,651) | |
Repayments of commercial paper, net | (3,982) | | | (7,960) | |
Other | (132) | | | (455) | |
Cash used in financing activities | (61,018) | | | (61,287) | |
| | | |
Increase in cash, cash equivalents and restricted cash | 3,184 | | | 2,152 | |
Cash, cash equivalents and restricted cash, ending balances | $ | 33,921 | | | $ | 27,129 | |
| | | |
Supplemental cash flow disclosure: | | | |
Cash paid for income taxes, net | $ | 14,531 | | | $ | 4,894 | |
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc. | Q2 2024 Form 10-Q | 5
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 – Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”).
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Note 2 – Revenue
Net sales disaggregated by significant products and services for the three- and six-month periods ended March 30, 2024 and April 1, 2023 were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
iPhone® | $ | 45,963 | | | $ | 51,334 | | | $ | 115,665 | | | $ | 117,109 | |
Mac® | 7,451 | | | 7,168 | | | 15,231 | | | 14,903 | |
iPad® | 5,559 | | | 6,670 | | | 12,582 | | | 16,066 | |
Wearables, Home and Accessories | 7,913 | | | 8,757 | | | 19,866 | | | 22,239 | |
Services | 23,867 | | | 20,907 | | | 46,984 | | | 41,673 | |
Total net sales | $ | 90,753 | | | $ | 94,836 | | | $ | 210,328 | | | $ | 211,990 | |
Total net sales include $3.3 billion of revenue recognized in the three months ended March 30, 2024 that was included in deferred revenue as of December 30, 2023, $3.5 billion of revenue recognized in the three months ended April 1, 2023 that was included in deferred revenue as of December 31, 2022, $5.1 billion of revenue recognized in the six months ended March 30, 2024 that was included in deferred revenue as of September 30, 2023, and $5.5 billion of revenue recognized in the six months ended April 1, 2023 that was included in deferred revenue as of September 24, 2022.
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 10, “Segment Information and Geographic Data” for the three- and six-month periods ended March 30, 2024 and April 1, 2023, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
As of March 30, 2024 and September 30, 2023, the Company had total deferred revenue of $12.6 billion and $12.1 billion, respectively. As of March 30, 2024, the Company expects 64% of total deferred revenue to be realized in less than a year, 26% within one-to-two years, 9% within two-to-three years and 1% in greater than three years.
Apple Inc. | Q2 2024 Form 10-Q | 6
Note 3 – Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 30, 2024 and April 1, 2023 (net income in millions and shares in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Numerator: | | | | | | | |
Net income | $ | 23,636 | | | $ | 24,160 | | | $ | 57,552 | | | $ | 54,158 | |
| | | | | | | |
Denominator: | | | | | | | |
Weighted-average basic shares outstanding | 15,405,856 | | | 15,787,154 | | | 15,457,810 | | | 15,839,939 | |
Effect of dilutive share-based awards | 58,853 | | | 59,896 | | | 62,865 | | | 61,445 | |
Weighted-average diluted shares | 15,464,709 | | | 15,847,050 | | | 15,520,675 | | | 15,901,384 | |
| | | | | | | |
Basic earnings per share | $ | 1.53 | | | $ | 1.53 | | | $ | 3.72 | | | $ | 3.42 | |
Diluted earnings per share | $ | 1.53 | | | $ | 1.52 | | | $ | 3.71 | | | $ | 3.41 | |
Approximately 48 million restricted stock units (“RSUs”) were excluded from the computation of diluted earnings per share for the six months ended April 1, 2023 because their effect would have been antidilutive.
Note 4 – Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of March 30, 2024 and September 30, 2023 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 30, 2024 |
| Adjusted Cost | | Unrealized Gains | | Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Current Marketable Securities | | Non-Current Marketable Securities |
Cash | $ | 28,227 | | | $ | — | | | $ | — | | | $ | 28,227 | | | $ | 28,227 | | | $ | — | | | $ | — | |
Level 1: | | | | | | | | | | | | | |
Money market funds | 1,353 | | | — | | | — | | | 1,353 | | | 1,353 | | | — | | | — | |
Mutual funds | 464 | | | 66 | | | (7) | | | 523 | | | — | | | 523 | | | — | |
Subtotal | 1,817 | | | 66 | | | (7) | | | 1,876 | | | 1,353 | | | 523 | | | — | |
Level 2 (1): | | | | | | | | | | | | | |
U.S. Treasury securities | 18,150 | | | 1 | | | (933) | | | 17,218 | | | 1,895 | | | 4,133 | | | 11,190 | |
U.S. agency securities | 5,775 | | | — | | | (446) | | | 5,329 | | | 233 | | | 581 | | | 4,515 | |
Non-U.S. government securities | 17,319 | | | 37 | | | (666) | | | 16,690 | | | — | | | 11,289 | | | 5,401 | |
Certificates of deposit and time deposits | 976 | | | — | | | — | | | 976 | | | 656 | | | 320 | | | — | |
Commercial paper | 1,482 | | | — | | | — | | | 1,482 | | | 274 | | | 1,208 | | | — | |
Corporate debt securities | 71,612 | | | 90 | | | (3,694) | | | 68,008 | | | 57 | | | 15,096 | | | 52,855 | |
Municipal securities | 511 | | | — | | | (15) | | | 496 | | | — | | | 188 | | | 308 | |
Mortgage- and asset-backed securities | 24,044 | | | 37 | | | (2,046) | | | 22,035 | | | — | | | 1,117 | | | 20,918 | |
Subtotal | 139,869 | | | 165 | | | (7,800) | | | 132,234 | | | 3,115 | | | 33,932 | | | 95,187 | |
Total (2) | $ | 169,913 | | | $ | 231 | | | $ | (7,807) | | | $ | 162,337 | | | $ | 32,695 | | | $ | 34,455 | | | $ | 95,187 | |
| | | | | | | | | | | | | |
Apple Inc. | Q2 2024 Form 10-Q | 7
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| September 30, 2023 |
| Adjusted Cost | | Unrealized Gains | | Unrealized Losses | | Fair Value | | Cash and Cash Equivalents | | Current Marketable Securities | | Non-Current Marketable Securities |
Cash | $ | 28,359 | | | $ | — | | | $ | — | | | $ | 28,359 | | | $ | 28,359 | | | $ | — | | | $ | — | |
Level 1: | | | | | | | | | | | | | |
Money market funds | 481 | | | — | | | — | | | 481 | | | 481 | | | — | | | — | |
Mutual funds and equity securities | 442 | | | 12 | | | (26) | | | 428 | | | — | | | 428 | | | — | |
Subtotal | 923 | | | 12 | | | (26) | | | 909 | | | 481 | | | 428 | | | — | |
Level 2 (1): | | | | | | | | | | | | | |
U.S. Treasury securities | 19,406 | | | — | | | (1,292) | | | 18,114 | | | 35 | | | 5,468 | | | 12,611 | |
U.S. agency securities | 5,736 | | | — | | | (600) | | | 5,136 | | | 36 | | | 271 | | | 4,829 | |
Non-U.S. government securities | 17,533 | | | 6 | | | (1,048) | | | 16,491 | | | — | | | 11,332 | | | 5,159 | |
Certificates of deposit and time deposits | 1,354 | | | — | | | — | | | 1,354 | | | 1,034 | | | 320 | | | — | |
Commercial paper | 608 | | | — | | | — | | | 608 | | | — | | | 608 | | | — | |
Corporate debt securities | 76,840 | | | 6 | | | (5,956) | | | 70,890 | | | 20 | | | 12,627 | | | 58,243 | |
Municipal securities | 628 | | | — | | | (26) | | | 602 | | | — | | | 192 | | | 410 | |
Mortgage- and asset-backed securities | 22,365 | | | 6 | | | (2,735) | | | 19,636 | | | — | | | 344 | | | 19,292 | |
Subtotal | 144,470 | | | 18 | | | (11,657) | | | 132,831 | | | 1,125 | | | 31,162 | | | 100,544 | |
Total (2) | $ | 173,752 | | | $ | 30 | | | $ | (11,683) | | | $ | 162,099 | | | $ | 29,965 | | | $ | 31,590 | | | $ | 100,544 | |
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
(2)As of March 30, 2024 and September 30, 2023, total marketable securities included $14.0 billion and $13.8 billion, respectively, that were restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements.
The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of March 30, 2024 (in millions):
| | | | | |
Due after 1 year through 5 years | $ | 67,987 | |
Due after 5 years through 10 years | 9,108 | |
Due after 10 years | 18,092 | |
Total fair value | $ | 95,187 | |
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
Foreign Exchange Rate Risk
To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of March 30, 2024, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 18 years.
The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
Apple Inc. | Q2 2024 Form 10-Q | 8
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.
The notional amounts of the Company’s outstanding derivative instruments as of March 30, 2024 and September 30, 2023 were as follows (in millions):
| | | | | | | | | | | |
| March 30, 2024 | | September 30, 2023 |
Derivative instruments designated as accounting hedges: | | | |
Foreign exchange contracts | $ | 60,265 | | | $ | 74,730 | |
Interest rate contracts | $ | 17,625 | | | $ | 19,375 | |
| | | |
Derivative instruments not designated as accounting hedges: | | | |
Foreign exchange contracts | $ | 75,552 | | | $ | 104,777 | |
The carrying amounts of the Company’s hedged items in fair value hedges as of March 30, 2024 and September 30, 2023 were as follows (in millions):
| | | | | | | | | | | |
| March 30, 2024 | | September 30, 2023 |
Hedged assets/(liabilities): | | | |
Current and non-current marketable securities | $ | 15,045 | | | $ | 14,433 | |
Current and non-current term debt | $ | (16,817) | | | $ | (18,247) | |
Accounts Receivable
Trade Receivables
The Company’s third-party cellular network carriers accounted for 34% and 41% of total trade receivables as of March 30, 2024 and September 30, 2023, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of March 30, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 47% and 19%. As of September 30, 2023, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 48% and 23%.
Note 5 – Condensed Consolidated Financial Statement Details
The following table shows the Company’s condensed consolidated financial statement details as of March 30, 2024 and September 30, 2023 (in millions):
Property, Plant and Equipment, Net
| | | | | | | | | | | |
| March 30, 2024 | | September 30, 2023 |
Gross property, plant and equipment | $ | 115,243 | | | $ | 114,599 | |
Accumulated depreciation | (71,697) | | | (70,884) | |
Total property, plant and equipment, net | $ | 43,546 | | | $ | 43,715 | |
Apple Inc. | Q2 2024 Form 10-Q | 9
Note 6 – Debt
Commercial Paper
The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of March 30, 2024 and September 30, 2023, the Company had $2.0 billion and $6.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the six months ended March 30, 2024 and April 1, 2023 (in millions):
| | | | | | | | | | | |
| Six Months Ended |
| March 30, 2024 | | April 1, 2023 |
Maturities 90 days or less: | | | |
Repayments of commercial paper, net | $ | (3,982) | | | $ | (5,315) | |
| | | |
Maturities greater than 90 days: | | | |
| | | |
Repayments of commercial paper | — | | | (2,645) | |
| | | |
| | | |
Total repayments of commercial paper, net | $ | (3,982) | | | $ | (7,960) | |
Term Debt
As of March 30, 2024 and September 30, 2023, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $102.6 billion and $105.1 billion, respectively (collectively the “Notes”). As of March 30, 2024 and September 30, 2023, the fair value of the Company’s Notes, based on Level 2 inputs, was $91.6 billion and $90.8 billion, respectively.
Note 7 – Shareholders’ Equity
Share Repurchase Program
During the six months ended March 30, 2024, the Company repurchased 248 million shares of its common stock for $44.0 billion. The Company’s share repurchase program does not obligate the Company to acquire a minimum amount of shares. Under the program, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Note 8 – Share-Based Compensation
Restricted Stock Units
A summary of the Company’s RSU activity and related information for the six months ended March 30, 2024 is as follows:
| | | | | | | | | | | | | | | | | |
| Number of RSUs (in thousands) | | Weighted-Average Grant Date Fair Value Per RSU | | Aggregate Fair Value (in millions) |
Balance as of September 30, 2023 | 180,247 | | | $ | 135.91 | | | |
RSUs granted | 75,826 | | | $ | 171.78 | | | |
RSUs vested | (47,027) | | | $ | 113.44 | | | |
RSUs canceled | (5,195) | | | $ | 126.83 | | | |
Balance as of March 30, 2024 | 203,851 | | | $ | 154.66 | | | $ | 34,956 | |
The fair value as of the respective vesting dates of RSUs was $821 million and $8.6 billion for the three- and six-month periods ended March 30, 2024, respectively, and was $1.1 billion and $8.0 billion for the three- and six-month periods ended April 1, 2023, respectively.
Apple Inc. | Q2 2024 Form 10-Q | 10
Share-Based Compensation
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 30, 2024 and April 1, 2023 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Share-based compensation expense | $ | 2,964 | | | $ | 2,686 | | | $ | 5,961 | | | $ | 5,591 | |
Income tax benefit related to share-based compensation expense | $ | (663) | | | $ | (620) | | | $ | (1,898) | | | $ | (1,798) | |
As of March 30, 2024, the total unrecognized compensation cost related to outstanding RSUs was $24.7 billion, which the Company expects to recognize over a weighted-average period of 2.7 years.
Note 9 – Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.
Note 10 – Segment Information and Geographic Data
The following table shows information by reportable segment for the three- and six-month periods ended March 30, 2024 and April 1, 2023 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Americas: | | | | | | | |
Net sales | $ | 37,273 | | | $ | 37,784 | | | $ | 87,703 | | | $ | 87,062 | |
Operating income | $ | 15,074 | | | $ | 13,927 | | | $ | 35,431 | | | $ | 31,791 | |
| | | | | | | |
Europe: | | | | | | | |
Net sales | $ | 24,123 | | | $ | 23,945 | | | $ | 54,520 | | | $ | 51,626 | |
Operating income | $ | 9,991 | | | $ | 9,368 | | | $ | 22,702 | | | $ | 19,385 | |
| | | | | | | |
Greater China: | | | | | | | |
Net sales | $ | 16,372 | | | $ | 17,812 | | | $ | 37,191 | | | $ | 41,717 | |
Operating income | $ | 6,700 | | | $ | 7,531 | | | $ | 15,322 | | | $ | 17,968 | |
| | | | | | | |
Japan: | | | | | | | |
Net sales | $ | 6,262 | | | $ | 7,176 | | | $ | 14,029 | | | $ | 13,931 | |
Operating income | $ | 3,135 | | | $ | 3,394 | | | $ | 6,954 | | | $ | 6,630 | |
| | | | | | | |
Rest of Asia Pacific: | | | | | | | |
Net sales | $ | 6,723 | | | $ | 8,119 | | | $ | 16,885 | | | $ | 17,654 | |
Operating income | $ | 2,806 | | | $ | 3,268 | | | $ | 7,385 | | | $ | 7,119 | |
Apple Inc. | Q2 2024 Form 10-Q | 11
A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 30, 2024 and April 1, 2023 is as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Segment operating income | $ | 37,706 | | | $ | 37,488 | | | $ | 87,794 | | | $ | 82,893 | |
Research and development expense | (7,903) | | | (7,457) | | | (15,599) | | | (15,166) | |
Other corporate expenses, net | (1,903) | | | (1,713) | | | (3,922) | | | (3,393) | |
Total operating income | $ | 27,900 | | | $ | 28,318 | | | $ | 68,273 | | | $ | 64,334 | |
Apple Inc. | Q2 2024 Form 10-Q | 12
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Item and other sections of this Quarterly Report on Form 10-Q (“Form 10-Q”) contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. For example, statements in this Form 10-Q regarding the potential future impact of macroeconomic conditions on the Company’s business and results of operations are forward-looking statements. Forward-looking statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of the 2023 Form 10-K under the heading “Risk Factors.” The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Unless otherwise stated, all information presented herein is based on the Company’s fiscal calendar, and references to particular years, quarters, months or periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
The following discussion should be read in conjunction with the 2023 Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) and the condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Form 10-Q.
Available Information
The Company periodically provides certain information for investors on its corporate website, www.apple.com, and its investor relations website, investor.apple.com. This includes press releases and other information about financial performance, information on environmental, social and governance matters, and details related to the Company’s annual meeting of shareholders. The information contained on the websites referenced in this Form 10-Q is not incorporated by reference into this filing. Further, the Company’s references to website URLs are intended to be inactive textual references only.
Business Seasonality and Product Introductions
The Company has historically experienced higher net sales in its first quarter compared to other quarters in its fiscal year due in part to seasonal holiday demand. Additionally, new product and service introductions can significantly impact net sales, cost of sales and operating expenses. The timing of product introductions can also impact the Company’s net sales to its indirect distribution channels as these channels are filled with new inventory following a product launch, and channel inventory of an older product often declines as the launch of a newer product approaches. Net sales can also be affected when consumers and distributors anticipate a product introduction.
During the second quarter of 2024, the Company announced an updated MacBook Air® 13-in. and MacBook Air 15-in.
Fiscal Period
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively.
Macroeconomic Conditions
Macroeconomic conditions, including inflation, interest rates and currency fluctuations, have directly and indirectly impacted, and could in the future materially impact, the Company’s results of operations and financial condition.
Apple Inc. | Q2 2024 Form 10-Q | 13
Segment Operating Performance
The following table shows net sales by reportable segment for the three- and six-month periods ended March 30, 2024 and April 1, 2023 (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | Change | | March 30, 2024 | | April 1, 2023 | | Change |
Net sales by reportable segment: | | | | | | | | | | | |
Americas | $ | 37,273 | | | $ | 37,784 | | | (1) | % | | $ | 87,703 | | | $ | 87,062 | | | 1 | % |
Europe | 24,123 | | | 23,945 | | | 1 | % | | 54,520 | | | 51,626 | | | 6 | % |
Greater China | 16,372 | | | 17,812 | | | (8) | % | | 37,191 | | | 41,717 | | | (11) | % |
Japan | 6,262 | | | 7,176 | | | (13) | % | | 14,029 | | | 13,931 | | | 1 | % |
Rest of Asia Pacific | 6,723 | | | 8,119 | | | (17) | % | | 16,885 | | | 17,654 | | | (4) | % |
Total net sales | $ | 90,753 | | | $ | 94,836 | | | (4) | % | | $ | 210,328 | | | $ | 211,990 | | | (1) | % |
Americas
Americas net sales were relatively flat during the second quarter of 2024 compared to the second quarter of 2023, with lower net sales of iPhone and iPad offset by higher net sales of Services. Year-over-year Americas net sales were relatively flat during the first six months of 2024, with higher net sales of Services offset by lower net sales of iPhone and iPad. The strength in foreign currencies relative to the U.S. dollar had a net favorable year-over-year impact on Americas net sales during the second quarter and first six months of 2024.
Europe
Europe net sales were relatively flat during the second quarter of 2024 compared to the second quarter of 2023, with higher net sales of Services offset by lower net sales of iPhone. The weakness in foreign currencies relative to the U.S. dollar had a net unfavorable year-over-year impact on Europe net sales during the second quarter of 2024. Year-over-year Europe net sales increased during the first six months of 2024 due primarily to higher net sales of iPhone and Services, partially offset by lower net sales of iPad.
Greater China
Greater China net sales decreased during the second quarter and first six months of 2024 compared to the same periods in 2023 due primarily to lower net sales of iPhone and iPad. The weakness in the renminbi relative to the U.S. dollar had an unfavorable year-over-year impact on Greater China net sales during the second quarter and first six months of 2024.
Japan
Japan net sales decreased during the second quarter of 2024 compared to the second quarter of 2023 due primarily to lower net sales of iPhone. Year-over-year Japan net sales during the first six months of 2024 were relatively flat. The weakness in the yen relative to the U.S. dollar had an unfavorable year-over-year impact on Japan net sales during the second quarter and first six months of 2024.
Rest of Asia Pacific
Rest of Asia Pacific net sales decreased during the second quarter of 2024 compared to the second quarter of 2023 due primarily to lower net sales of iPhone. Year-over-year Rest of Asia Pacific net sales decreased during the first six months of 2024 due primarily to lower net sales of Wearables, Home and Accessories and iPad.
Apple Inc. | Q2 2024 Form 10-Q | 14
Products and Services Performance
The following table shows net sales by category for the three- and six-month periods ended March 30, 2024 and April 1, 2023 (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | Change | | March 30, 2024 | | April 1, 2023 | | Change |
Net sales by category: | | | | | | | | | | | |
iPhone | $ | 45,963 | | | $ | 51,334 | | | (10) | % | | $ | 115,665 | | | $ | 117,109 | | | (1) | % |
Mac | 7,451 | | | 7,168 | | | 4 | % | | 15,231 | | | 14,903 | | | 2 | % |
iPad | 5,559 | | | 6,670 | | | (17) | % | | 12,582 | | | 16,066 | | | (22) | % |
Wearables, Home and Accessories | 7,913 | | | 8,757 | | | (10) | % | | 19,866 | | | 22,239 | | | (11) | % |
Services | 23,867 | | | 20,907 | | | 14 | % | | 46,984 | | | 41,673 | | | 13 | % |
Total net sales | $ | 90,753 | | | $ | 94,836 | | | (4) | % | | $ | 210,328 | | | $ | 211,990 | | | (1) | % |
iPhone
iPhone net sales decreased during the second quarter of 2024 compared to the second quarter of 2023 due to lower net sales of Pro models. Year-over-year iPhone net sales were relatively flat during the first six months of 2024.
Mac
Mac net sales increased during the second quarter and first six months of 2024 compared to the same periods in 2023 due to higher net sales of laptops.
iPad
iPad net sales decreased during the second quarter and first six months of 2024 compared to the same periods in 2023 due primarily to lower net sales of iPad Pro® and iPad 9th generation.
Wearables, Home and Accessories
Wearables, Home and Accessories net sales decreased during the second quarter and first six months of 2024 compared to the same periods in 2023 due primarily to lower net sales of Wearables and Accessories.
Services
Services net sales increased during the second quarter and first six months of 2024 compared to the same periods in 2023 due primarily to higher net sales from advertising, the App Store® and cloud services.
Apple Inc. | Q2 2024 Form 10-Q | 15
Gross Margin
Products and Services gross margin and gross margin percentage for the three- and six-month periods ended March 30, 2024 and April 1, 2023 were as follows (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Gross margin: | | | | | | | |
Products | $ | 24,462 | | | $ | 27,134 | | | $ | 62,480 | | | $ | 62,757 | |
Services | 17,809 | | | 14,842 | | | 34,646 | | | 29,551 | |
Total gross margin | $ | 42,271 | | | $ | 41,976 | | | $ | 97,126 | | | $ | 92,308 | |
| | | | | | | | | | | | | | | | | | | | | | | |
Gross margin percentage: | | | | | | | |
Products | 36.6 | % | | 36.7 | % | | 38.3 | % | | 36.8 | % |
Services | 74.6 | % | | 71.0 | % | | 73.7 | % | | 70.9 | % |
Total gross margin percentage | 46.6 | % | | 44.3 | % | | 46.2 | % | | 43.5 | % |
Products Gross Margin
Products gross margin decreased during the second quarter of 2024 compared to the second quarter of 2023 due primarily to lower Products volume and the weakness in foreign currencies relative to the U.S. dollar. Year-over-year Products gross margin was relatively flat during the first six months of 2024.
Products gross margin percentage was relatively flat during the second quarter of 2024 compared to the second quarter of 2023. Year-over-year Products gross margin percentage increased during the first six months of 2024 due primarily to cost savings, partially offset by the weakness in foreign currencies relative to the U.S. dollar.
Services Gross Margin
Services gross margin and Services gross margin percentage increased during the second quarter and first six months of 2024 compared to the same periods in 2023 due primarily to a different Services mix.
The Company’s future gross margins can be impacted by a variety of factors, as discussed in Part I, Item 1A of the 2023 Form 10-K under the heading “Risk Factors.” As a result, the Company believes, in general, gross margins will be subject to volatility and downward pressure.
Operating Expenses
Operating expenses for the three- and six-month periods ended March 30, 2024 and April 1, 2023 were as follows (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Research and development | $ | 7,903 | | | $ | 7,457 | | | $ | 15,599 | | | $ | 15,166 | |
Percentage of total net sales | 9 | % | | 8 | % | | 7 | % | | 7 | % |
Selling, general and administrative | $ | 6,468 | | | $ | 6,201 | | | $ | 13,254 | | | $ | 12,808 | |
Percentage of total net sales | 7 | % | | 7 | % | | 6 | % | | 6 | % |
Total operating expenses | $ | 14,371 | | | $ | 13,658 | | | $ | 28,853 | | | $ | 27,974 | |
Percentage of total net sales | 16 | % | | 14 | % | | 14 | % | | 13 | % |
Research and Development
The growth in research and development (“R&D”) expense during the second quarter and first six months of 2024 compared to the same periods in 2023 was driven primarily by increases in headcount-related expenses.
Apple Inc. | Q2 2024 Form 10-Q | 16
Selling, General and Administrative
The growth in selling, general and administrative expense during the second quarter and first six months of 2024 compared to the same periods in 2023 was driven in part by higher infrastructure-related costs.
Provision for Income Taxes
Provision for income taxes, effective tax rate and statutory federal income tax rate for the three- and six-month periods ended March 30, 2024 and April 1, 2023 were as follows (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| March 30, 2024 | | April 1, 2023 | | March 30, 2024 | | April 1, 2023 |
Provision for income taxes | $ | 4,422 | | | $ | 4,222 | | | $ | 10,829 | | | $ | 9,847 | |
Effective tax rate | 15.8 | % | | 14.9 | % | | 15.8 | % | | 15.4 | % |
Statutory federal income tax rate | 21 | % | | 21 | % | | 21 | % | | 21 | % |
The Company’s effective tax rate for the second quarter and first six months of 2024 was lower than the statutory federal income tax rate due primarily to a lower effective tax rate on foreign earnings, the impact of the U.S. federal R&D credit, and tax benefits from share-based compensation, partially offset by state income taxes.
The Company’s effective tax rate for the second quarter and first six months of 2024 was higher compared to the same periods in 2023 due primarily to a higher effective tax rate on foreign earnings and a lower tax benefit from the U.S. federal R&D credit.
Liquidity and Capital Resources
The Company believes its balances of cash, cash equivalents and unrestricted marketable securities, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.
The Company’s contractual cash requirements have not changed materially since the 2023 Form 10-K, except for manufacturing purchase obligations.
Manufacturing Purchase Obligations
The Company utilizes several outsourcing partners to manufacture subassemblies for the Company’s products and to perform final assembly and testing of finished products. The Company also obtains individual components for its products from a wide variety of individual suppliers. As of March 30, 2024, the Company had manufacturing purchase obligations of $34.2 billion, with $34.1 billion payable within 12 months.
Capital Return Program
In addition to its contractual cash requirements, the Company has an authorized share repurchase program, under which the remaining availability was $30.1 billion as of March 30, 2024. On May 2, 2024, the Company announced the Board of Directors had authorized an additional program to repurchase up to $110 billion of the Company’s common stock. The programs do not obligate the Company to acquire a minimum amount of shares.
On May 2, 2024, the Company also announced the Board of Directors raised the Company’s quarterly cash dividend from $0.24 to $0.25 per share, beginning with the dividend to be paid during the third quarter of 2024. The Company intends to increase its dividend on an annual basis, subject to declaration by the Board of Directors.
During the second quarter of 2024, the Company repurchased $23.5 billion of its common stock and paid dividends and dividend equivalents of $3.7 billion.
Apple Inc. | Q2 2024 Form 10-Q | 17
Recent Accounting Pronouncements
Income Taxes
In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The Company will adopt ASU 2023-09 in its fourth quarter of 2026. ASU 2023-09 allows for adoption using either a prospective or retrospective transition method.
Segment Reporting
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company’s chief operating decision maker (“CODM”). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The Company will adopt ASU 2023-07 in its fourth quarter of 2025 using a retrospective transition method.
Critical Accounting Estimates
The preparation of financial statements and related disclosures in conformity with GAAP and the Company’s discussion and analysis of its financial condition and operating results require the Company’s management to make judgments, assumptions and estimates that affect the amounts reported. Note 1, “Summary of Significant Accounting Policies” of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q and in the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2023 Form 10-K describe the significant accounting policies and methods used in the preparation of the Company’s condensed consolidated financial statements. There have been no material changes to the Company’s critical accounting estimates since the 2023 Form 10-K.